\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ the\\ patient\\ underwent\\ ureteroscopy\\ and\\ biopsy\\.\\ \\ the\\ patient\\ subsequently\\ underwent\\ a\\ right\\ nephrectomy\\ and\\ resection\\ of\\ the\\ righ\\ ureter\\.\ \(0\)\
\-\ 2\\.6\\ cm\\ x\\ 1\\.0\\ cm\\ soft\\ tissue\\ mass\\ within\\ the\\ right\\ renal\\ collecting\\ system\\.\ \(1\)\
\-\ urothelial\\ carcinoma\\ \\-\\ high\\ grade\\ non\\-invasive\\ papillary\\ transitional\\ cell\\ carcinoma\\.\ \(0\)\
\-\ \\â\\€\\¢\\	transitional\\ cell\\ carcinoma\ \(0\)\
\-\ \\â\\€\\¢\\	squamous\\ cell\\ carcinoma\ \(0\)\
\-\ \\â\\€\\¢\\	primary\\ adenocarcinoma\\ \\(very\\ rare\\)\ \(0\)\
\-\ \\â\\€\\¢\\	metastatic\\ disease\\ \\(typ\\ tcc\\,\\ or\\ direct\\ invasion\\ from\\ other\\ neoplasms\\)\ \(0\)\
\-\ 55\\ y\\/o\\ female\\ with\\ abdominal\\ pain\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ transitional\\:\\ 0\\.12457141632167591\ \(0\)\
\-\ carcinoma\\:\\ 0\\.11532988904837459\ \(0\)\
\-\ typ\\:\\ 0\\.10494664790436307\ \(0\)\
\-\ ureteroscopy\\:\\ 0\\.09186793018212366\ \(0\)\
\-\ righ\\:\\ 0\\.09186793018212366\ \(0\)\
\-\ cell\\:\\ 0\\.08243716827076736\ \(0\)\
\-\ non\\-invasive\\:\\ 0\\.08178105089179981\ \(0\)\
\-\ tcc\\:\\ 0\\.07878921245988427\ \(0\)\
\-\ urothelial\\:\\ 0\\.07753492060681491\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0746197310283756\ \(0\)\
\-\ underwent\\:\\ 0\\.06981419132090998\ \(0\)\
\-\ 2\\.6\\:\\ 0\\.06711267373355419\ \(0\)\
\-\ 1\\.0\\:\\ 0\\.06332155788690497\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.05768126798112353\ \(0\)\
\-\ ureter\\:\\ 0\\.054890783387803954\ \(0\)\
\-\ cm\\:\\ 0\\.05457038375754728\ \(0\)\
\-\ collecting\\:\\ 0\\.05191870390134512\ \(0\)\
\-\ neoplasms\\:\\ 0\\.05178107506323708\ \(0\)\
\-\ papillary\\:\\ 0\\.051645019160574894\ \(0\)\
\-\ squamous\\:\\ 0\\.049771302806391214\ \(0\)\
\-\ 55\\:\\ 0\\.04931773320838799\ \(0\)\
\-\ invasion\\:\\ 0\\.04898854831159621\ \(0\)\
\-\ direct\\:\\ 0\\.04805232060541629\ \(0\)\
\-\ subsequently\\:\\ 0\\.0461175714447285\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.04394707672099094\ \(0\)\
\-\ system\\:\\ 0\\.04005333298096188\ \(0\)\
\-\ rare\\:\\ 0\\.03950416903182495\ \(0\)\
\-\ grade\\:\\ 0\\.03874805705894012\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.03757185962151044\ \(0\)\
\-\ very\\:\\ 0\\.036926019267346774\ \(0\)\
\-\ biopsy\\:\\ 0\\.03609158620996143\ \(0\)\
\-\ x\\:\\ 0\\.03356031351604139\ \(0\)\
\-\ resection\\:\\ 0\\.031725186375240695\ \(0\)\
\-\ renal\\:\\ 0\\.03056518511259606\ \(0\)\
\-\ primary\\:\\ 0\\.030135526939234478\ \(0\)\
\-\ y\\/o\\:\\ 0\\.02817415511690048\ \(0\)\
\-\ high\\:\\ 0\\.02783983406043828\ \(0\)\
\-\ metastatic\\:\\ 0\\.02560844528114393\ \(0\)\
\-\ abdominal\\:\\ 0\\.025427609977644226\ \(0\)\
\-\ soft\\:\\ 0\\.02477293766658988\ \(0\)\
\-\ tissue\\:\\ 0\\.02411215700538802\ \(0\)\
\-\ other\\:\\ 0\\.023448077960743434\ \(0\)\
\-\ \\-\\:\\ 0\\.021806291175099565\ \(0\)\
\-\ right\\:\\ 0\\.02146742164548611\ \(0\)\
\-\ female\\:\\ 0\\.020913812755331353\ \(0\)\
\-\ patient\\:\\ 0\\.02039504597419971\ \(0\)\
\-\ within\\:\\ 0\\.019406326290310496\ \(0\)\
\-\ \\(\\:\\ 0\\.017199088720091918\ \(0\)\
\-\ \\)\\:\\ 0\\.016988992669364406\ \(0\)\
\-\ disease\\:\\ 0\\.016627827871615524\ \(0\)\
\-\ from\\:\\ 0\\.015076615632788242\ \(0\)\
\-\ mass\\:\\ 0\\.01414834532080434\ \(0\)\
\-\ pain\\:\\ 0\\.01242390675631827\ \(0\)\
\-\ or\\:\\ 0\\.011922889868615566\ \(0\)\
\-\ the\\:\\ 0\\.006583299271601228\ \(0\)\
\-\ a\\:\\ 0\\.004721426212126205\ \(0\)\
\-\ and\\:\\ 0\\.004285928707909963\ \(0\)\
\-\ \\,\\:\\ 0\\.003222738875205802\ \(0\)\
\-\ \\.\\:\\ 0\\.0021130676248420402\ \(0\)\
\-\ with\\:\\ 0\\.0013929068582129729\ \(0\)\
\-\ of\\:\\ 0\\.0013869500094998621\ \(0\)\
